Proteomic studies included both gel-based and label-free mass spectrometric surveys of dystrophin-deficient heart muscle from the established mdx animal model of dystrophinopathy. This evidence concerns the gene DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.